港澳免费资料大全-免费完整资料

Stock code002923

中 | EN
  • Home
  • About us
    Company ProfileSubsidiary companiesOur HistoryBusiness StrategySocial Responsibility
  • News
  • Products
    APIINTERMEDIATEFDFPELLETSR&D LIST
  • R&D
    R&D Team
  • Marketing
    Formulation MarketingAPI MarketingExhibition
  • EHS
  • FAQ
  • Careers
  • Contact us
中 | EN
Products
  • API
  • INTERMEDIATE
  • FDF
  • PELLETS
  • R&D LIST
Home > Products > R&D LIST

No.

Product

Specification

DMF

Status

Cas No.

1

拉考沙胺

Lacosamide

EP

2018

P

175481-36-4

2

盐酸度洛西汀

Duloxetine HCl

EP USP

2018

V

136434-34-9

3

右旋兰索拉唑

Dexlansoprazole

IHS

2019

L

138530-94-6

4

苯甲酸阿格列汀

Alogliptin Benzoate

IHS

2018

V

850649-62-6

5

阿齐沙坦酯钾

Azilsartan Kamedoxomil

IHS

2019

L

863031-24-7

6

磷酸西格列汀

Sitagliptin Phosphate

EP USP

2018

P

654671-77-9

7

甲磺酸沙芬酰胺

Safinamide Mesylate

IHS

2019

L

202825-46-5

8

贝曲沙班

Betrixaban

IHS

2019

L

330942-05-7

9

罗沙司他

Roxadustat

IHS

2019

L

808118-40-3

10

伐度司他

Vadadustat

IHS

2019

L

1000025-07-9

11

雷西纳德

Lesinurad

IHS

2019

L

878672-00-5

L:Lab    V:Validition   P:Pilot   C:Comerical   IHS:In House Specification

Contact  |  E-mail  |  OA office
© Rundu Pharma. ALL RIGHTS RESERVED.   |  互联网药品信息服务资格证:(粤)-非经营性-2019-0108
港澳免费资料大全